Vuse: BAT's E-Liquid Enters Korean E-Cigarette Market

VUSE by 2FIRSTS.ai
Dec.11.2023
Vuse: BAT's E-Liquid Enters Korean E-Cigarette Market
BAT Korea introduced 'Vuse' in the Korean market, aiming to compete with KT&G's Lil and PMI's IQOS.

On December 10th, according to Naver news, Eunji Kim, the CEO of British American Tobacco (BAT) Korea, introduced 'Vuse' to the Korean market. Currently, BAT ranks third in the domestic e-cigarette market in South Korea (where HNB products are considered e-cigarettes), following KT&G's Lil and PMI's IQOS.

 

According to Kim Eun-jee, "Lil and IQOS are tobacco while Vuse is an e-liquid. Vuse has proven its competitiveness in the US market, so it should be able to challenge the current status quo.

 

The newly launched 'Vuse Go 800' has sold out within a month of its release. It is reported that in the first week after the initial batch of products hit the market, Vuse's market share in the e-cigarette market in Korea increased by approximately four times, prompting plans to expand sales nationwide from next year.

 

Kim En-zhi emphasized that the key marketing point of Vuse is its safety. Apart from the e-liquid produced in the manufacturing phase, users are not allowed to randomly change the internal e-liquid.

 

She said, "It is difficult for us to accurately know what ingredients are added in e-cigarettes sold through numerous informal channels. Once the safety of Vuse is known, the threat to users' health from using e-cigarettes will disappear.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Council of State has suspended a government decree that was set to ban the manufacture, production and export of nicotine pouches from April 2026. The court ruled that companies were not given sufficient time to reorganise their operations. A final decision on the legality of the decree is expected by June 2026. The court noted that the commercial sale of nicotine pouches is already restricted under existing public health laws.
Dec.23 by 2FIRSTS.ai
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
Moldova adopts new sanitary rules for tobacco products, e-cigarettes and related goods
Moldova adopts new sanitary rules for tobacco products, e-cigarettes and related goods
Moldova is introducing new sanitary standards for tobacco products, e-cigarettes and related goods, with regulations adopted on January 14 aimed at protecting public health and tightening control over tobacco sales. The rules include measures to limit minors’ access to tobacco products, including via online shops, and establish procedures for notifications, reporting and market monitoring.
Jan.16 by 2FIRSTS.ai
Two Taunton Shops Closed After Seizure of Illegal Tobacco and Vapes
Two Taunton Shops Closed After Seizure of Illegal Tobacco and Vapes
Two shops in Taunton have been ordered to close for three months after authorities found illegal tobacco and vape products worth around £50,000. The seizures followed joint operations involving Trading Standards officers, police and tobacco detection dogs. Magistrates ruled that closing the premises was necessary to prevent further criminal activity.
Dec.23 by 2FIRSTS.ai
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria has released its full-year 2025 results, reporting full-year net revenues of $23.279 billion, down 3.1% year over year. Domestic cigarette shipment volume fell 10% for the year. on! nicotine pouches reached a 7.7% share of the U.S. oral tobacco category in the fourth quarter. NJOY posted $21 million in net revenues in Q4, while full-year net revenues were negative $13 million (mainly due to returns and related factors).
Jan.30 by 2FIRSTS.ai
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11